BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24571671)

  • 41. Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell disease.
    Karkoska K; Appiah-Kubi A; Rocker J; Stoffels G; Aygun B
    Br J Haematol; 2019 Sep; 186(6):855-860. PubMed ID: 31148158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postoperative morphine consumption in children with sickle-cell disease.
    Crawford MW; Galton S; Naser B
    Paediatr Anaesth; 2006 Feb; 16(2):152-7. PubMed ID: 16430411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral morphine protocol evaluation for the treatment of vaso-occlusive crisis in paediatric sickle cell patients.
    Paquin H; D Trottier E; Robitaille N; Pastore Y; Dore Bergeron MJ; Bailey B
    Paediatr Child Health; 2019 Feb; 24(1):e45-e50. PubMed ID: 30792609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral analgesia for treatment of painful crisis in sickle cell anemia.
    Friedman EW; Webber AB; Osborn HH; Schwartz S
    Ann Emerg Med; 1986 Jul; 15(7):787-91. PubMed ID: 3729099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Death from a morphine infusion during a sickle cell crisis.
    Gerber N; Apseloff G
    J Pediatr; 1993 Aug; 123(2):322-5. PubMed ID: 8345436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
    Allen Liles E; Kirsch J; Gilchrist M; Adem M
    Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain.
    de Franceschi L; Finco G; Vassanelli A; Zaia B; Ischia S; Corrocher R
    Haematologica; 2004 Nov; 89(11):1389-91. PubMed ID: 15531461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous Lidocaine as an Adjuvant for Pain Associated with Sickle Cell Disease.
    Nguyen NL; Kome AM; Lowe DK; Coyne P; Hawks KG
    J Pain Palliat Care Pharmacother; 2015; 29(4):359-64. PubMed ID: 26654408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sickle cell disease in the emergency department.
    Lovett PB; Sule HP; Lopez BL
    Emerg Med Clin North Am; 2014 Aug; 32(3):629-47. PubMed ID: 25060254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease.
    Givens M; Rutherford C; Joshi G; Delaney K
    J Emerg Med; 2007 Apr; 32(3):239-43. PubMed ID: 17394984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults.
    Bartolucci P; El Murr T; Roudot-Thoraval F; Habibi A; Santin A; Renaud B; Noël V; Michel M; Bachir D; Galactéros F; Godeau B
    Blood; 2009 Oct; 114(18):3742-7. PubMed ID: 19717646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
    Olabode JO; Shokunbi WA
    West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of patient-controlled analgesia for patients with acute abdominal pain in the emergency department: a randomized trial.
    Birnbaum A; Schechter C; Tufaro V; Touger R; Gallagher EJ; Bijur P
    Acad Emerg Med; 2012 Apr; 19(4):370-7. PubMed ID: 22506940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anxiolytic medication as an adjunct to morphine analgesia for acute low back pain management in the emergency department: a prospective randomized trial.
    Behrbalk E; Halpern P; Boszczyk BM; Parks RM; Chechik O; Rosen N; Shapira A; Merose O; Uri O
    Spine (Phila Pa 1976); 2014 Jan; 39(1):17-22. PubMed ID: 24270933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of refractory pain in hospitalized adolescents with sickle cell disease: changing from intravenous opioids to continuous infusion epidural analgesia.
    New T; Venable C; Fraser L; Rosenberg E; Schmidt J; James-Herry A; Osunkwo I; Dampier C
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e398-402. PubMed ID: 24136017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sufentanil is not superior to morphine for the treatment of acute traumatic pain in an emergency setting: a randomized, double-blind, out-of-hospital trial.
    Bounes V; Barthélémy R; Diez O; Charpentier S; Montastruc JL; Ducassé JL
    Ann Emerg Med; 2010 Nov; 56(5):509-16. PubMed ID: 20382445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous opioid dosing and outcomes in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Am J Emerg Med; 2010 Nov; 28(9):1041-1050.e6. PubMed ID: 20825766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is there an ideal morphine dose for prehospital treatment of severe acute pain? A randomized, double-blind comparison of 2 doses.
    Bounes V; Charpentier S; Houze-Cerfon CH; Bellard C; Ducassé JL
    Am J Emerg Med; 2008 Feb; 26(2):148-54. PubMed ID: 18272093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.